Autres langues Valbiotis

Actions

ALVAL

FR0013254851

Recherche biotechnologique et médicale

Marché Fermé - Euronext Paris 17:55:00 07/10/2026			Varia. 5j.	Varia. 1 janv.
0,6000 ^EUR	-5,81%		-13,04%	-13,54%

22/09	Valbiotis annonce des résultats positifs de l’étude clinique Cardio-Liver et le lancement commercial de ValbiotisPRO® Foie	CI
22/07	Valbiotis publie les résultats de l'étude clinique REVERSE-IT évaluant Totum 63 dans Nature Communications	CI

Autres langues

22/09	Valbiotis Announces Positive Results from the Cardio-Liver Clinical Study and Commercial Launch of Valbiotispro® Foie
22/09	VALBIOTIS SA: Valbiotis announces positive results from the Cardio-Liver clinical study - Commercial launch of ValbiotisPRO® Foie on September 23
27/07	VALBIOTIS SA: Cardiovascular Prevention Act: A response to a major public health challenge A milestone fully aligned with Valbiotis’ mission
22/07	Valbiotis Publishes Results of Reverse-It Clinical Study Evaluating Totum 63 in Nature Communications
22/07	VALBIOTIS SA: Results of the REVERSE-IT clinical study published in Nature Communications, a major international scientific recognition for the ingredient Totum•63
29/06	Valbiotis Raises EUR10 Million for Commercial Development, Working Capital
26/06	VALBIOTIS SA: Valbiotis announces the success of its capital increase of €10.2M
08/06	Valbiotis Secures Exclusive Distributor in Qatar
08/06	Valbiotis and Al Danah Medical Company Signs Exclusive Distribution Agreement for Valbiotispro Range in Qatar
08/06	VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintained PSR in the amount of €10.2M secured by commitments amounting to 76.6%
08/06	VALBIOTIS SA: Valbiotis announces the signing of an exclusive distribution agreement in Qatar, a new milestone in the brand’s expansion in the Middle East
27/05	VALBIOTIS SA: Monacolins from Red Yeast Rice: On May 13, EU Member States voted in favor of the draft regulation aimed at banning monacolins from red yeast rice
27/05	Valbiotis SA Announces EU Member States Vote in Favor of Regulation Banning Monacolins From Red Yeast Rice
11/05	Valbiotis and Aika Form Joint Venture and Establish Subsidiary in Singapore
11/05	Valbiotis announces creation by Chinese JV of subsidiary in Singapore
11/05	VALBIOTIS SA: Valbiotis continues its expansion in Asia
23/04	Valbiotis Expands E-Commerce Delivery Service to Belgium and Luxembourg
23/04	VALBIOTIS SA: Valbiotis expands its e-commerce to Belgium and Luxembourg
17/04	Valbiotis SA Announces Appointments to Supervisory Board
17/04	VALBIOTIS SA: General Meeting of April 17, 2026: All Resolutions Approved
19/03	VALBIOTIS SA: Valbiotis announces launch of operations in Asia
19/03	Valbiotis SA Announces Launch Of Operations In Asia
10/03	VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
03/03	French and Benelux stocks-Factors to watch
02/03	VALBIOTIS SA: 2025 Financial Results